AKTS
Aktis Oncology, Inc.
18.50$
+0.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -93.3% | +7,020.2% | +19.5% | +24.0% | +757.5% | -100.0% | – | -94.5% | +336.9% | |
| – | – | +282.9% | +826.1% | -0.6% | +138.3% | +707.2% | – | – | -7.2% | – | |
| – | – | -141.2% | – | +128.3% | -245.1% | – | – | – | – | +336.9% | |
| – | +273.4% | +151.7% | +199.8% | +45.1% | +6.6% | +74.0% | -59.9% | +81.2% | +58.0% | +64.7% | |
| – | +219.0% | +105.1% | +46.3% | -1.2% | +25.2% | +90.2% | -75.3% | +50.4% | +47.2% | +11.4% | |
| – | +262.8% | +124.7% | +121.3% | +26.6% | +12.4% | +79.6% | -65.0% | +76.0% | +53.9% | +51.6% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +776.1% | +58.5% | -98.3% | – | – | +14.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -187.8% | – | +728.5% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.